215 related articles for article (PubMed ID: 31038845)
1. The prognostic comparison among unilateral, bilateral, synchronous bilateral, and metachronous bilateral breast cancer: A meta-analysis of studies from recent decade (2008-2018).
Pan B; Xu Y; Zhou YD; Yao R; Wu HW; Zhu QL; Wang CJ; Mao F; Lin Y; Shen SJ; Sun Q
Cancer Med; 2019 Jun; 8(6):2908-2918. PubMed ID: 31038845
[TBL] [Abstract][Full Text] [Related]
2. Bilateral breast cancer, synchronous and metachronous; differences and outcome.
Jobsen JJ; van der Palen J; Ong F; Riemersma S; Struikmans H
Breast Cancer Res Treat; 2015 Sep; 153(2):277-83. PubMed ID: 26268697
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological features and prognosis of bilateral breast cancer: a single-center cohort study based on Chinese data.
Hong C; Zheng Y; Geng R; Hu H; Zhong Y; Guan Q; Zhang Y; Li X
Ann Transl Med; 2022 Jul; 10(13):742. PubMed ID: 35957718
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Breast Conservation Therapy in Early Stage Bilateral Breast Cancer.
Lee MM; Heimann R; Powers C; Weichselbaum RR; Chen LM
Breast J; 1999 Jan; 5(1):36-41. PubMed ID: 11348254
[TBL] [Abstract][Full Text] [Related]
5. Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up.
Eliyatkin N; Zengel B; Yagci A; Comut E; Postaci H; Uslu A; Aktas S
Asian Pac J Cancer Prev; 2015; 16(12):4921-6. PubMed ID: 26163616
[TBL] [Abstract][Full Text] [Related]
6. A Retrospective Study on the Clinicopathologic Characteristics and Outcomes of 179 Cases of Synchronous and Metachronous Bilateral Breast Cancer in China.
Jia H; Zheng Y; Wang P; Wei Z; Li X; Fu G; Wang C
Clin Breast Cancer; 2022 Apr; 22(3):e341-e349. PubMed ID: 34728164
[TBL] [Abstract][Full Text] [Related]
7. Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
Wadasadawala T; Lewis S; Parmar V; Budrukkar A; Gupta S; Nair N; Shet T; Badwe R; Sarin R
Clin Breast Cancer; 2018 Aug; 18(4):e727-e737. PubMed ID: 29254601
[TBL] [Abstract][Full Text] [Related]
8. Synchronous and metachronous bilateral breast cancer: clinicopathologic characteristics and prognostic outcomes.
Mruthyunjayappa S; Zhang K; Zhang L; Eltoum IA; Siegal GP; Wei S
Hum Pathol; 2019 Oct; 92():1-9. PubMed ID: 31351153
[TBL] [Abstract][Full Text] [Related]
9. Bilateral breast cancer in China: A 10-year single-center retrospective study (2006-2016).
Jiang H; Zhang R; Liu X; Ran R; Zhang J; Liu Y; Gui X; Chen Y; Li K; Shao B; Yan Y; Liang X; Song G; Di L; Li H
Cancer Med; 2021 Sep; 10(17):6089-6098. PubMed ID: 34346560
[TBL] [Abstract][Full Text] [Related]
10. Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer.
Ding S; Sun X; Lu S; Wang Z; Chen X; Shen K
Breast; 2021 Jun; 57():71-79. PubMed ID: 33774461
[TBL] [Abstract][Full Text] [Related]
11. Comparison of prognosis and clinical features between synchronous bilateral and unilateral breast cancers.
Karakas Y; Kertmen N; Lacin S; Aslan A; Demir M; Ates O; Aksoy S; Altundag K
J BUON; 2017; 22(3):623-627. PubMed ID: 28730766
[TBL] [Abstract][Full Text] [Related]
12. Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis focused on cell cycle regulation.
Senkus E; Szade J; Pieczyńska B; Kunc M; Pliszka A; Jassem J
Histol Histopathol; 2018 Jan; 33(1):55-64. PubMed ID: 28276034
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Characteristics, Treatment and Outcome of 123 Patients with Synchronous or Metachronous Bilateral Breast Cancer in a Swiss Institutional Retrospective Series.
Huber A; Seidler SJ; Huber DE
Eur J Breast Health; 2020 Apr; 16(2):129-136. PubMed ID: 32285035
[TBL] [Abstract][Full Text] [Related]
14. The prognosis of synchronous and metachronous bilateral breast cancer in Chinese patients.
Liang X; Li D; Geng W; Cao X; Xiao C
Tumour Biol; 2013 Apr; 34(2):995-1004. PubMed ID: 23296702
[TBL] [Abstract][Full Text] [Related]
15. Racial and Ethnic Disparities in Synchronous and Metachronous Bilateral Breast Cancer.
Hewitt DB; Li Y; Bhattacharyya O; Fisher JL; Stover D; Obeng-Gyasi S
J Racial Ethn Health Disparities; 2023 Jun; 10(3):1035-1046. PubMed ID: 35386052
[TBL] [Abstract][Full Text] [Related]
16. Bilateral breast cancers in an Asian population, and a comparison between synchronous and metachronous tumours.
Sim Y; Tan VKM; Sidek NAB; Chia DKA; Tan BKT; Madhukumar P; Yong WS; Wong CY; Ong KW
ANZ J Surg; 2018 Oct; 88(10):982-987. PubMed ID: 30141242
[TBL] [Abstract][Full Text] [Related]
17. Synchronous and metachronous bilateral breast cancer among women with a history of lobular carcinoma in situ.
Mallory MA; Whiting K; Park A; Gönen M; Gilbert E; King TA; Pilewskie ML
Breast Cancer Res Treat; 2022 Jul; 194(1):137-148. PubMed ID: 35488092
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and prognostic analysis of metachronous bilateral breast carcinoma: a retrospective study based on propensity score matching.
Wang X; Wang X; Cai L; Zhang C; Li Y
Clin Transl Oncol; 2024 May; ():. PubMed ID: 38801511
[TBL] [Abstract][Full Text] [Related]
19. Comparison of claudin-3 and claudin-4 expression in bilateral and unilateral breast cancer.
Szade J; Kunc M; Pieczyńska-Uziębło B; Świerblewski M; Biernat W; Jassem J; Senkus E
Neoplasma; 2021 Mar; 68(2):283-289. PubMed ID: 33147053
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003-2017).
Pan B; Xu Y; Zhou Y; Yao R; Zhou X; Xu Y; Ren X; Xiao M; Zhu Q; Kong L; Mao F; Lin Y; Zhang X; Shen S; Sun Q
Breast Cancer Res Treat; 2022 Nov; 196(2):409-422. PubMed ID: 36166112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
